Mackenzie Financial
TBPH icon

Mackenzie Financial’s Theravance Biopharma TBPH Stock Holding History

Mackenzie Financial’s Portfolio TBPH Stock Details TBPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$16.8M Buy
985,848
+737,166
+296% +$12.2M 0.02% 492
2026
Q1 		$4.04M Buy
248,682
+211,353
+566% +$3.74M ﹤0.01% 730
2025
Q4 		$705K Buy
+37,329
New +$619K ﹤0.01% 1137
2020
Q2 		– Sell
-33,910
Closed -$784K – 1125
2020
Q1 		$784K Buy
+33,910
New +$849K ﹤0.01% 702

Other funds holding TBPH

MAP
Madison Avenue Partners New York $2.32B AUM 132.6% 1-Year Est. Return
WAM
Weiss Asset Management Boston, Massachusetts $9.54B AUM 55.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NM
Newtyn Management New York $801M AUM 23.14% 1-Year Est. Return
ICM
Irenic Capital Management New York $2.08B AUM 19.87% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Mackenzie Financial's TBPH Position: Q2 2026 in Review

Mackenzie Financial increased its Theravance Biopharma (TBPH) stake by 296% in Q2 2026, buying an estimated $12.2M and bringing the position to 985,848 shares worth $16.8M. The position accounts for 0.02% of the portfolio, ranked #492.

Mackenzie Financial first reported a position in TBPH in Q1 2020 and has held it in 4 quarters since. 181 funds tracked by Wall St. Rank hold TBPH as of Q2 2026.

  • Mackenzie Financial held 985,848 shares of Theravance Biopharma worth $16.8M as of Q2 2026.
  • Mackenzie Financial bought 737,166 Theravance Biopharma shares in Q2 2026, an estimated $12.2M.
  • Theravance Biopharma made up 0.02% of Mackenzie Financial's portfolio in Q2 2026, its #492 holding.
  • Mackenzie Financial first reported a position in Theravance Biopharma in Q1 2020 and has held it in 4 quarters since.
  • 181 funds tracked by Wall St. Rank held Theravance Biopharma as of Q2 2026.

Based on Mackenzie Financial's 13F filing for Q2 2026, filed 13 Aug 2026.